Delivery Order SPE2DR25D2011-SPE2DR26FADWP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,165.71 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging) on January 28, 2026, with completion scheduled for January 29, 2026. This contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was awarded through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the corporate headquarters for...
- The Defense Logistics Agency awarded a delivery order valued at $33,819.84 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,971.19. The contract is scheduled for completion by December 30, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,909.06 on January 27, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price delivery order with a completion date of January 28, 2026, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent...
- The Defense Logistics Agency awarded a Delivery Order valued at $8,406.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This competitively awarded, firm fixed-price contract was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $11,485.27 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 22, 2026, with completion targeted for January 23, 2026. This firm fixed-price, non-set-aside contract was executed to support federal medical procurement needs, with performance fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.84 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count) on January 26, 2026, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, non-set-aside contract performed out of the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor in the...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency awarded a delivery order valued at approximately $14K to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on January 26, 2026, with completion scheduled for January 27, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,330.33 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADWPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $89,553.56 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier to federal medical procurement operations, particularly for military and veteran healthcare systems. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2031. The IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora/AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.6k | 1/29/26 |